Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Stanek

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Wiener Klinische Wochenschrift|January 1, 1996
Acceptance of a pump-driven infusion therapy with prostaglandin E1 as a bridge to heart transplantationH Daneschvar, R Pacher, S Rödler, et al.
Journal of Primary Care & Community Health|August 23, 2025
Intralesional Injection of Vitamin D3 for Treatment of Cutaneous Warts: A Randomized, Double-Blind, Placebo-Controlled TrialStephen P Merry, David N Brennan, Michelle J Duvall, et al.
Transplantation Proceedings|March 20, 1999
Effects of continuous, long-term therapy with prostaglandin E1 preoperatively on outcome after heart transplantationB Frey, A Zuckermann, J Koller-Strametz, et al.
Transplantation Proceedings|February 1, 1997
Validation of big endothelin plasma levels compared with established neurohumoral markers in patients with severe chronic heart failureB Stanek, B Frey, M Hülsmann, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 1, 1997
Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failureM Hülsmann, B Stanek, B Frey, et al.
European Heart Journal|August 1, 1996
Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failureR Pacher, B Stanek, S Globits, et al.
European Heart Journal|February 1, 1997
Prostaglandin E1--bridge to cardiac transplantation. Technique, dosage, resultsR Pacher, B Stanek, M Hülsmann, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 1, 1997
Prostaglandin E1 infusion compared with prostacyclin infusion in patients with refractory heart failure: effects on hemodynamics and neurohumoral variablesR Pacher, B Stanek, M Hülsmann, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 5, 1999
Bridging to heart transplantation: prostaglandin E1 versus prostacyclin versus dobutamineB Stanek, B Sturm, B Frey, et al.
Journal of the American College of Cardiology|March 1, 1996
Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failureR Pacher, B Stanek, M Hülsmann, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Wiener Klinische Wochenschrift|January 1, 1996
Acceptance of a pump-driven infusion therapy with prostaglandin E1 as a bridge to heart transplantationH Daneschvar, R Pacher, S Rödler, et al.
Journal of Primary Care & Community Health|August 23, 2025
Intralesional Injection of Vitamin D3 for Treatment of Cutaneous Warts: A Randomized, Double-Blind, Placebo-Controlled TrialStephen P Merry, David N Brennan, Michelle J Duvall, et al.
Transplantation Proceedings|March 20, 1999
Effects of continuous, long-term therapy with prostaglandin E1 preoperatively on outcome after heart transplantationB Frey, A Zuckermann, J Koller-Strametz, et al.
Transplantation Proceedings|February 1, 1997
Validation of big endothelin plasma levels compared with established neurohumoral markers in patients with severe chronic heart failureB Stanek, B Frey, M Hülsmann, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 1, 1997
Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failureM Hülsmann, B Stanek, B Frey, et al.
European Heart Journal|August 1, 1996
Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failureR Pacher, B Stanek, S Globits, et al.
European Heart Journal|February 1, 1997
Prostaglandin E1--bridge to cardiac transplantation. Technique, dosage, resultsR Pacher, B Stanek, M Hülsmann, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 1, 1997
Prostaglandin E1 infusion compared with prostacyclin infusion in patients with refractory heart failure: effects on hemodynamics and neurohumoral variablesR Pacher, B Stanek, M Hülsmann, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 5, 1999
Bridging to heart transplantation: prostaglandin E1 versus prostacyclin versus dobutamineB Stanek, B Sturm, B Frey, et al.
Journal of the American College of Cardiology|March 1, 1996
Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failureR Pacher, B Stanek, M Hülsmann, et al.
Pageof 8